tiprankstipranks
Star Health & Allied Insurance Co. Ltd. (IN:STARHEALTH)
:STARHEALTH
India Market
Want to see IN:STARHEALTH full AI Analyst Report?

Star Health & Allied Insurance Co. Ltd. (STARHEALTH) AI Stock Analysis

2 Followers

Top Page

IN:STARHEALTH

Star Health & Allied Insurance Co. Ltd.

(STARHEALTH)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
₹587.00
▲(27.68% Upside)
Action:UpgradedDate:04/30/26
The score is driven primarily by solid financial performance (low leverage, rising equity, and improving cash generation), partially offset by slowing growth and softer earnings/returns since 2024. Technicals are supportive due to a strong uptrend but are tempered by overbought signals, while valuation is a notable headwind given the high P/E.
Positive Factors
Low leverage / strong balance sheet
Very low debt and rising equity provide a durable capital buffer for an insurer, supporting solvency, regulatory margins and the ability to absorb claim volatility. This financing conservatism enables long-term underwriting capacity expansion and reduces refinancing risk across cycles.
Negative Factors
Revenue growth slowdown
A sharp deceleration in premium growth reduces operating leverage and constrains future earnings expansion. Persistently slower GWP could reflect pricing pressure, distribution limits or market saturation, making it harder to restore prior earnings momentum over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Very low debt and rising equity provide a durable capital buffer for an insurer, supporting solvency, regulatory margins and the ability to absorb claim volatility. This financing conservatism enables long-term underwriting capacity expansion and reduces refinancing risk across cycles.
Read all positive factors

Star Health & Allied Insurance Co. Ltd. (STARHEALTH) vs. iShares MSCI India ETF (INDA)

Star Health & Allied Insurance Co. Ltd. Business Overview & Revenue Model

Company Description
Star Health and Allied Insurance Company Limited provides health insurance products. It offers retail health products to various customer segments, including individuals, families, students, and senior citizens, as well as persons with pre-existin...
How the Company Makes Money
STARHEALTH makes money primarily by underwriting health insurance risk and investing the funds it holds. Its key revenue streams are: (1) Gross Written Premium (GWP)/Net Written Premium from selling health insurance policies to retail customers an...

Star Health & Allied Insurance Co. Ltd. Financial Statement Overview

Summary
Strong balance sheet with low leverage and rising equity/assets, alongside improved profitability versus 2021–2022 and stronger 2026 operating/free cash flow. Offsetting this, revenue growth has cooled materially in 2026 and net income/returns have stepped down since the 2024 peak, suggesting some margin/underwriting pressure.
Income Statement
72
Positive
Balance Sheet
82
Very Positive
Cash Flow
79
Positive
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue171.11B178.33B164.88B144.13B122.41B106.02B
Gross Profit119.87B64.58B138.61B121.61B104.13B91.10B
EBITDA6.01B7.54B9.98B12.68B9.67B-13.05B
Net Income5.33B5.57B6.46B8.45B6.19B-10.41B
Balance Sheet
Total Assets212.70B240.64B207.85B180.54B163.58B152.79B
Cash, Cash Equivalents and Short-Term Investments0.0014.44B6.58B13.68B10.49B12.11B
Total Debt4.70B4.70B4.70B4.70B4.70B7.20B
Total Liabilities136.68B165.13B136.72B113.23B97.69B88.83B
Stockholders Equity76.02B75.51B71.12B67.32B65.89B63.96B
Cash Flow
Free Cash Flow0.0017.54B12.96B11.86B12.29B-340.86M
Operating Cash Flow0.0018.32B13.79B13.10B12.76B290.43M
Investing Cash Flow0.00-10.67B-11.51B-11.77B-10.97B-37.86B
Financing Cash Flow0.0096.50M-42.00M229.73M-2.68B25.36B

Star Health & Allied Insurance Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price459.75
Price Trends
50DMA
464.72
Positive
100DMA
462.78
Positive
200DMA
458.29
Positive
Market Momentum
MACD
7.64
Negative
RSI
71.86
Negative
STOCH
87.87
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:STARHEALTH, the sentiment is Positive. The current price of 459.75 is below the 20-day moving average (MA) of 465.48, below the 50-day MA of 464.72, and above the 200-day MA of 458.29, indicating a bullish trend. The MACD of 7.64 indicates Negative momentum. The RSI at 71.86 is Negative, neither overbought nor oversold. The STOCH value of 87.87 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:STARHEALTH.

Star Health & Allied Insurance Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹83.68B18.030.44%13.29%-2.17%
70
Outperform
₹309.06B48.3118.38%-14.07%
67
Neutral
₹85.48B-247.4716.15%-67.50%
65
Neutral
₹300.48B83.790.04%17.16%1.24%
57
Neutral
₹148.31B31.271.28%13.20%4.00%
54
Neutral
₹25.78B205.090.92%21.45%-41.40%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:STARHEALTH
Star Health & Allied Insurance Co. Ltd.
525.25
150.35
40.10%
IN:APLLTD
Alembic Pharmaceuticals Limited
754.50
-139.49
-15.60%
IN:HCG
HealthCare Global Enterprises Ltd.
572.55
-15.07
-2.56%
IN:MARKSANS
Marksans Pharma Limited
184.65
-36.92
-16.66%
IN:MEDANTA
Global Health Limited
1,117.65
-90.57
-7.50%
IN:MEDIASSIST
Medi Assist Healthcare Services Limited
345.15
-94.75
-21.54%

Star Health & Allied Insurance Co. Ltd. Corporate Events

Star Health Publishes Audited FY26 Results Extract in Newspapers
Apr 30, 2026
Star Health Allied Insurance Company Limited has published the extract of its audited standalone financial results for the quarter and financial year ended March 31, 2026 in leading English and Tamil newspapers. The disclosure, made in line with ...
Star Health Releases Q4 and FY 2026 Investor Presentation Ahead of Earnings Call
Apr 28, 2026
Star Health Allied Insurance has released an investor presentation detailing its financial and operational performance for the fourth quarter and full year ended March 31, 2026. The materials will be used in an earnings call with investors and an...
Star Health Board Clears FY26 Audited Results With Clean Audit Opinion
Apr 28, 2026
Star Health Allied Insurance Co. Ltd. announced that its board has approved the audited standalone financial results for the quarter and full year ended March 31, 2026, at a meeting held on April 28, 2026. The results were audited by joint statut...
Star Health Secures IRDAI Nod to Transfer Late Jhunjhunwala’s Shareholding
Apr 6, 2026
Star Health and Allied Insurance Company Limited has received IRDAI approval for the transmission of 8,28,82,958 equity shares previously held by late investor Rakesh Jhunjhunwala. The transfer will be executed in accordance with the probate grant...
Star Health Sets Short-Notice Analyst, Investor Meets in Mumbai
Mar 24, 2026
Star Health Allied Insurance Company Limited has scheduled a series of meetings with analysts and institutional investors in Mumbai on March 27, 2026, engaging firms including Abakkus Asset Manager, Sageone Investment Managers, Singularity AMC an...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 30, 2026